Why the study?
Comparative long-term clinical outcomes between patients with prediabetes and diabetes in patients with NSTEMI and multivessel disease undergoing PCI are not well known.
Does prediabetes worsen long-term clinical outcomes compared to normoglycemia in patients with NSTEMI and MVD undergoing PCI?
Does prediabetes worsen long-term clinical outcomes compared to normoglycemia in patients with NSTEMI and MVD undergoing PCI?
In patients with NSTEMI and multivessel disease undergoing PCI, prediabetes is associated with worse long-term outcomes that are comparable to those seen in patients with diabetes.
Answers are grounded in this paper and cite their sources.
Prediabetes may identify higher MACE risk comparable to diabetes after PCI for NSTEMI with MVD; leaves open whether glycemic intervention alters outcomes.
OBJECTIVE: The comparative long-term clinical outcomes between patients with prediabetes and diabetes in patients with non-ST-elevation myocardial infarction (NSTEMI) and multivessel disease (MVD) who were undergoing percutaneous coronary intervention (PCI) are not well known. We therefore compared the 2-year clinical outcomes in such patients. METHODS: A total of 2963 patients with NSTEMI and MVD [normoglycemia (group A, n = 629), prediabetes (group B, n = 802), and diabetes (group C, n = 1532)] were evaluated. The primary outcomes were the occurrence of major adverse cardiac events (MACE) defined as all-cause death, recurrent myocardial infarction (Re-MI), and any repeat revascularization. The secondary outcome was stent thrombosis. RESULTS: The cumulative incidence of MACE as well as for death or MI in group B and C were similar when compared to each other. However, they (P = 0.048 and P = 0.017, respectively and P = 0.022 and P = 0.001, respectively) were significantly higher than in group A. The cumulative incidence of all-cause death in group B (P = 0.042) and all-cause death and cardiac death in group C (P = 0.001 and P = 0.028, respectively) were significantly higher than in group A. However, those of all-cause death, cardiac death, Re-MI, any repeat revascularization, and ST were not significantly different between groups B and C. CONCLUSION: In this study, patients with NSTEMI and MVD who underwent successful implantation of newer-generation DES and were prediabetic had worse outcomes compared to normoglycemics and comparable to those with diabetes.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: